- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
14 result(s) found for: Periodontal surgery.
Displaying page 1 of 1.
EudraCT Number: 2006-005883-25 | Sponsor Protocol Number: Scil-MD05-C02 | Start Date*: 2007-04-25 | |||||||||||
Sponsor Name:Scil Technology GmbH | |||||||||||||
Full Title: Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison with Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001367-36 | Sponsor Protocol Number: DoxP-01/2006 | Start Date*: 2006-12-05 | |||||||||||
Sponsor Name:Prof. Dr. Peter Eickholz | |||||||||||||
Full Title: Benefit of adjunctive systemic postsurgical doxycycline in regenerative periodontal surgery | |||||||||||||
Medical condition: Periodontitis is an opportunistic infectious disease that destroys the periodontal attachment and bone. Bacterial plaque (biofilm) on the teeth adjacent to the gingiva is the necessary cause gingiv... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000869-20 | Sponsor Protocol Number: DC0071-BB-404-8B | Start Date*: 2005-08-08 |
Sponsor Name:Pierre Fabre Médicament | ||
Full Title: Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with sutu... | ||
Medical condition: Post-operative care for patients having periodontal surgery with gingival suture. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) EE (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005511-32 | Sponsor Protocol Number: XEOLAS | Start Date*: 2022-09-12 |
Sponsor Name:Xeolas Pharmaceuticals Ltd. | ||
Full Title: A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Study to confirm the Efficacy and Safety of “Effects of topical Alendronic Acid on alveolar bone remodeling af... | ||
Medical condition: Healthy patients periodontal disease, that qualify for oral surgery of the alveolar bone(ASA I and II) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001167-75 | Sponsor Protocol Number: FIBEA-04-EC-19-ALV | Start Date*: 2019-09-09 |
Sponsor Name:BTI I MAS D | ||
Full Title: Randomized Clinical Trial, conventional treatment-controlled, studying the efficacy of Plasma Rich in Growth Factor (PRGF®) in alveolar ridge preservation after simple exodontia in the anterior reg... | ||
Medical condition: Alveolar ridge preservation after exodontia of uniradiculate dental pience in the anterior region of maxilla | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000902-31 | Sponsor Protocol Number: ECACOR19 | Start Date*: 2019-09-05 |
Sponsor Name:OMEQUI | ||
Full Title: Healing efficacy after impacted mandibular third molar surgery with the use of autologous platelet-rich fibrin: a randomized controlled clinical study | ||
Medical condition: If the addition of L-PRF reduces postoperative pain and inflammation, as well as complications, after extraction of lower third molars | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001885-40 | Sponsor Protocol Number: Syst-AB+Sinus | Start Date*: 2022-02-24 |
Sponsor Name:Universidad Complutense de Madrid | ||
Full Title: The effect of systemic antibiotics on post-surgical complications and paitent-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor ... | ||
Medical condition: The medical condition that the patients have in this trial is edentulism in a posterior maxillary quadrant of the mouth with a sinus pneumatisation/ decreased crestal bone heigh defect requiring a... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006617-32 | Sponsor Protocol Number: 06/Q0605/1 | Start Date*: 2007-05-02 |
Sponsor Name:Kings College Hospital Trust R&D | ||
Full Title: A prospective randomised double blind parallel trial comparing Articaine versus Lignocaine for mandibular dentistry | ||
Medical condition: necessary dental surgery | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-005374-26 | Sponsor Protocol Number: ECAELEV21 | Start Date*: 2022-08-18 |
Sponsor Name:OMEQUI coordinator | ||
Full Title: Efficacy of platelet- and leukocyte-rich fibrin (L-PRF) in reducing healing time in sinus lift combined with deproteinized bovine mineralized bone (DBBM): randomized clinical trial. | ||
Medical condition: If the application of L-PRF with respect to the use of DBBM shows that there are differences in the percentage of new bone between the LPRF group and the control group at 4 and 6 months | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004564-26 | Sponsor Protocol Number: BAS20 | Start Date*: 2021-09-20 | |||||||||||
Sponsor Name:Karolinska Institute | |||||||||||||
Full Title: Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20) | |||||||||||||
Medical condition: Patients requiring bone augmentation procedure prior to, or in conjunction to installation of dental implants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004046-41 | Sponsor Protocol Number: 273551 | Start Date*: 2021-12-09 |
Sponsor Name:University of Bergen, | ||
Full Title: A multicentre clinical trial; Alveolar bone augmentation using Mesenchymal Stem Cells and biphasic calcium phosphate granules prior to dental implants | ||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004724-11 | Sponsor Protocol Number: 294568 | Start Date*: 2014-09-22 |
Sponsor Name:Karolinska Institute | ||
Full Title: Surgical treatment of peri-implantitis with and without systemically adjunctive antibiotics A prospective, open, randomized, three armed, parallel, placebo controlled clinical trial | ||
Medical condition: peri-implantitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006514-37 | Sponsor Protocol Number: DOAC-CO | Start Date*: 2023-02-08 | |||||||||||
Sponsor Name:Ente Ecclesiastico Ospedale Generale Regionale “F. Miulli” | |||||||||||||
Full Title: Haemorrhagic risk of direct oral anticoagulants (DOACs) in patients undergoing oral surgery | |||||||||||||
Medical condition: Patients on direct acting oral anticoagulants (DOACs) who are to undergo oral surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005244-42 | Sponsor Protocol Number: 20159990 | Start Date*: 2018-06-04 | |||||||||||||||||||||||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||||||||||||||||||||||
Full Title: An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Rich Tumors of Bone. | |||||||||||||||||||||||||||||||||
Medical condition: Aneurysmal bone cysts, giant cell granuloma, other giant cell rich lesions (primary bone, non-malignant) | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) FR (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
